Meningitis and encephalitis pathogens can manifest with similar symptoms. Traditional testing strategies require multiple assays to look for more than one pathogen at a time, are labor-intense and can take 48-72 hours to obtain results. This delay in receiving actionable information can lead to worsening symptoms, unnecessary antimicrobial and/or antiviral therapy and increased length of stay in the hospital. Equipped with a comprehensive meningitis/encephalitis PCR panel, scientists can test for a set of 14 of the most common bacterial, viral and fungal pathogens in a single test in about an hour. This can allow physicians to get clinically actionable information rapidly, potentially improving patient care, length of stay and costs.
In this free webinar, the featured speakers will discuss how collaboration between an infectious disease physician and a laboratory director made a difference in treating patients presenting with meningitis/encephalitis in a community hospital.
Javeed Siddiqui, MD, MPH, Co-founder and Chief Medical Officer, TeleMed2U, Inc., Roseville, California
Dr. Javeed Siddiqui is the co-founder and Chief Medical Officer for TeleMed2U, a 100% telemedicine based multi-specialty clinical practice. Dr. Siddiqui has been actively involved in telemedicine since 2002 and has been recognized as a national thought leader in the field. Dr. Siddiqui served as the Medical Director of one the nation’s top telemedicine programs at the University of California, Davis.
In addition to being an Infectious Diseases physician, Dr. Siddiqui is a recognized medical technologist who has previously held an appoint at the School of Engineering, University of California, Berkeley and served as the first Medical Director of California’s Institute for Science and Innovation, The Center for Information Technology Research in the Interest of Society [CITRIS].
Dr. Siddiqui co-found TeleMed2U in 2011. TeleMed2U has pioneered work in developing and implementing telemedicine services and programs to hospitals and outpatient clinics. In 2012 the Agency for Healthcare Research and Quality recognized the telemedicine based anti-microbial stewardship program developed by TeleMed2U as an innovative program in health care.
Dr. Siddiqui has lectured throughout the United States and Internationally on telemedicine and serves as an advisor and board member to a number of telemedicine and healthcare technology companiesMessage Presenter
Arpad Peter, BSMT, Director of Laboratories, Chief Clinical Laboratory Scientist, Adventist Health Howard Memorial, Willits, California
Arpad Peter is the director of laboratories at Adventist Health Howard Memorial. Mr. Peter has over 30 years of experience working in a community hospital setting and over a decade of experience working in a clinical laboratory. He obtained his Bachelor of Science in Medical Technology at Loma Linda University.Message Presenter
Who Should Attend?
This webinar will appeal to individuals with the following or related job titles:
- Pediatric Physicians
- Hospital Administrators
- Clinical Laboratorians
What You Will Learn
Attendees will learn about:
- The benefits of on-boarding the BioFire Meningitis/Encephalitis Panel in the community hospital setting
- What impact does hospital size have when considering a rapid multiplex diagnostic test
- Implementing a rapid multiplex diagnostic test for meningitis/encephalitis in a community hospital
With more than 25 years of molecular experience, BioFire Diagnostics, LLC sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing. The syndromic approach is a symptom-driven diagnostic method that combines a broad grouping of probable pathogenic causes into a single, rapid test. This allows physicians to easily choose the right test, the first time. Our innovative team leads the industry in infectious disease diagnostics and provides molecular solutions that lessen the time to medical results, empower healthcare professionals to make better diagnostic decisions and lower healthcare costs. We are committed to improving the quality of life for everyone, everywhere, every day.